Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sana'a A. Jaber"'
Publikováno v:
Heliyon, Vol 10, Iss 10, Pp e31266- (2024)
Warfarin, a widely prescribed anticoagulant, is highly effective for various coagulation disorders. However, its efficacy is limited by a narrow therapeutic index and frequent drug interactions, especially those involving metabolism by Cytochrome P45
Externí odkaz:
https://doaj.org/article/634e1cd188ef445ea28e25d7b1f1addb
Publikováno v:
Molecules, Vol 27, Iss 23, p 8582 (2022)
Capmatinib, a recently approved tyrosine kinase inhibitor, is used for the treatment of non-small cell lung cancer. We describe two new HPLC methods for capmatinib quantification in vivo and in vitro. HPLC with a fluorescence detection method was use
Externí odkaz:
https://doaj.org/article/878cdc74ec8b4bfd8c12f573321c0d12
Autor:
Aref L. Zayed, Ghuroob N. Hamadneh, Jomana Al Hroot, Abdulraouf Mayyas, Sana'a A. Jaber, Nidal A. Qinna
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 232:115423
Autor:
Saja B Alzughoul, Hala T Abu Kassab, Ayat J Abu Shameh, Mohammad K Alhazabreh, Sana'a A Jaber, Amani D Abu Kwiak, Salam S Abu Laila, Mays M Jaradat, Nour M Al-Daoud, Mo'tasem M Alsmadi
Publikováno v:
Biopharmaceutics & Drug Disposition. 42:263-284
Renal (RIP) and hepatic (HIP) impairments are prevalent conditions in cancer patients. They can cause changes in gastric emptying time, albumin levels, hematocrit, glomerular filtration rate, hepatic functional volume, blood flow rates, and metabolic